Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-EN | Version v6-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-12-13 | 2022-12-13 |
| Drug Identification Number | 00453811 | 00453811 |
| Brand name | HEPARIN LEO INJ 1000UNIT/ML | HEPARIN LEO INJ 1000UNIT/ML |
| Common or Proper name | Sodium Heparin injection | Sodium Heparin injection |
| Company Name | LEO PHARMA INC | LEO PHARMA INC |
| Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
| Strength(s) | 1000UNIT | 1000UNIT |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 10 x 10 mL vial | 10 x 10 mL vial |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-12-02 | 2022-12-02 |
| Actual start date | ||
| Estimated end date | 2022-12-12 | 2022-12-12 |
| Actual end date | 2022-12-12 | 2022-12-12 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Increase in demand due to competitor out of stock | Increase in demand due to competitor out of stock |
| Health Canada comments |